Mass Spectrometry Market is Growing Rapidly in Life Science and Clinical Sector

The demand for mass spectrometry is growing rapidly in life science and clinical sector. Some of its most common applications in life science and clinical studies are determination of protein structure, interactions and folding; protein identification from the mass of its peptide fragment; relative or absolute quantification of proteins in a given sample; monitoring of enzyme reactions; chemical modifications; protein digestion; forensic analysis; and disease biomarkers detection. All these applications are very vital in life science and clinical studies and with increasing healthcare awareness, advanced research and development, increasing cases of drug abuse, and high number of metabolic diseases, the demand for mass spectrometer is rapidly growing. Mass spectrometer is an important analytical tool for the study of proteins. Proteomics is very difficult to analyse and study, due to the complexity of its structures. Mass spectrometry helps to analyse the composition of different biological samples and offers quantitative proteogenomics and proteomics. All these factors tend to drive the growth of the mass spectrometry market.

Get report sample at:

Europe had the second largest share in the mass spectrometry market in 2015, with 26.0% share. Increasing food safety concern, growing demand in life science & clinical analysis sector and technological advancements are the key growth drivers of the European market. High compliance with international GMP & GDP certification for pharmaceutical excipients has high positive impact on the European market for mass spectrometry. Forensic science and new product development offer ample growth opportunities for the European market.

Germany held the largest share (23.4%) in the European mass spectrometry market in 2015. The major factors driving the growth of the German market are high healthcare expenditure, increasing research and development for drug discovery, increasing demand for clinical testing and increasing environment applications.

The key companies operating in the mass spectrometry market include Danaher Corporation, Shimadzu Corporation, Thermo Fisher Scientific Inc., Bruker Corporation, Agilent Technologies Inc., Waters Corporation, PerkinElmer Inc., LECO Corporation, Dani Instruments S.p.A, Protea Biosciences Group Inc., Microsaic Systems PLC, Endress+Hauser Inc., Jeol USA Inc., and Elico Ltd.

By Platform
  • Hybrid Mass Spectrometry
    • Triple Quadrupole Mass Spectrometry
    • Quadrupole Time-of-Flight (Q TOF) Mass Spectrometry
    • Fourier Transform Mass Spectrometry (FTMS)
  • Single Mass Spectrometry
    • Quadrupole Mass Spectrometry
    • Ion Trap Mass Spectrometry
    • Time-of-Flight (TOF) Mass Spectrometry
  • Other Mass Spectrometry
By Application
  • Drug discovery and development
  • Proteomics
  • Clinical Testing
  • Environment
  • Others
By End User
  • Pharmaceuticals
  • Life science and Biotechnology
  • Academic and Research Institute
  • Hospitals
  • Others
By Geography
  • North America - U.S., Canada, and Rest of North America
  • Europe - Germany, France, U.K., Italy, Spain and Rest of Europe
  • Asia - China, Japan, India, and Rest of Asia
  • Rest of the World - Brazil, Australia and Others


Popular posts from this blog

Mental Health Software Market Insights, Share, Growth Drivers and Future Scope

Europe Drug of Abuse Testing Market Analysis, Share, Growth Drivers and Forecast by 2023

Medical Coding Market Projected to Have a Stable Growth for the Upcoming Years